The rise of immuno-oncology in China: a challenge to western dominance?

Mark P. Lythgoe*, Grant Lewison, Ajay Aggarwal, Chris Booth, Mark Lawler, Dario Trapani, Manju Sengar, Richard Sullivan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)439-441
Number of pages3
JournalLancet Oncology
Volume24
Issue number5
DOIs
Publication statusPublished - May 2023

Keywords

  • Neoplasms - epidemiology - therapy
  • Immunotherapy - adverse effects
  • Medical Oncology
  • China - epidemiology
  • Humans

Cite this